Aytu Bioscience Inc., of Englewood, Colo. said clinical data for Natesto (testosterone), a nasal gel approved as a replacement therapy for men diagnosed with hypogonadism, has shown that the pharmacokinetics, safety and efficacy of Natesto for restoring normal testosterone levels in men with low testosterone levels is not adversely affected by seasonal allergies.